IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors
Clinical trial NCT05991518 · UNKNOWN
Trial details
- NCT number
- NCT05991518
- Sponsor
- SUNHO（China）BioPharmaceutical CO., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-12-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.